Zoledronic Acid Inhibits TSC2-null Cell Tumor Growth via RhoA/YAP Signaling Pathway in Mouse Models of Lymphangioleiomyomatosis
Cancer Cell International - United Kingdom
doi 10.1186/s12935-020-1131-4
Full Text
Open PDFAbstract
Available in full text
Date
February 10, 2020
Authors
Publisher
Springer Science and Business Media LLC